When switching, start the new medications at a lower dose to avoid the risk of these side effects
Our experience and the available data suggest that individuals with a pre-existing history of GI issues, such as GERD, peptic ulcer disease, or prior gastritis, are at a higher risk
Gastrointestinal side effects caused 5.6% of semaglutide patients to stop their medication entirely, compared to only 2.7% of tirzepatide patients.[1] That's roughly half the dropout rate due to GI issues
Approximately 25-40% of weight loss-related requests receive initial denials, but comprehensive medical records and provider advocacy significantly improve authorization chances
This curated collection supports healing, protects your investment, and sustains long-term skin health
The 26-page lawsuit, filed on behalf of a Louisiana woman, asserts that the drug companies failed to adequately warn patients about the possible risk of severe stomach problems associated with their blockbuster drugs Ozempic and Mounjaro, according to the court filing